UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study

European archives of psychiatry and clinical neuroscience, 2015-10, Vol.265 (7), p.589-600

2015

Link zum Volltext

Verfügbarkeit prüfen

Tourette syndrome is associated with insecure attachment and higher aggression

International journal of neuroscience, 2015-07, Vol.125 (7), p.521-525

2015

Link zum Volltext

Verfügbarkeit prüfen

Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients

Progress in neuro-psychopharmacology & biological psychiatry, 2021-04, Vol.107, p.110226-110226, Article 110226

2021

Link zum Volltext

Verfügbarkeit prüfen

Tryptophan metabolism and immunogenetics in major depression: A role for interferon-γ gene

Brain, behavior, and immunity, 2013-07, Vol.31, p.128-133

2013

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders

European archives of psychiatry and clinical neuroscience, 2017-08, Vol.267 (5), p.377-389

2017

Link zum Volltext

Verfügbarkeit prüfen

Prenatal immunologic predictors of postpartum depressive symptoms: a prospective study for potential diagnostic markers

European archives of psychiatry and clinical neuroscience, 2014-10, Vol.264 (7), p.615-624

2014

Link zum Volltext

Verfügbarkeit prüfen

Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder

Bipolar disorders, 2016-03, Vol.18 (2), p.155-163

2016

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study

Neuropsychobiology, 2019, Vol.77 (1), p.13-22

2019

Link zum Volltext

Verfügbarkeit prüfen

ICAM G241A Polymorphism and Soluble ICAM-1 Serum Levels: Evidence for an Active Immune Process in Schizophrenia

Neuroimmunomodulation, 2005-01, Vol.12 (1), p.54-59

2005

Link zum Volltext

Verfügbarkeit prüfen

Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6

European archives of psychiatry and clinical neuroscience, 2012-08, Vol.262 (5), p.393-401

2012

Link zum Volltext

Verfügbarkeit prüfen

Association between intracellular infectious agents and Tourette’s syndrome

European archives of psychiatry and clinical neuroscience, 2010-06, Vol.260 (4), p.359-363

2010

Link zum Volltext

Verfügbarkeit prüfen

Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

Progress in neuro-psychopharmacology & biological psychiatry, 2014-06, Vol.51, p.190-195

2014

Link zum Volltext

Verfügbarkeit prüfen

Cost of illness in patients with Gilles de la Tourette’s syndrome

Journal of neurology, 2010-07, Vol.257 (7), p.1055-1061

2010

Link zum Volltext

Verfügbarkeit prüfen

Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics

European archives of psychiatry and clinical neuroscience, 2008-08, Vol.258 (6), p.335-344

2008

Link zum Volltext

Verfügbarkeit prüfen

A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome

Psychiatric genetics, 2010-02, Vol.20 (1), p.35-38

2010

Link zum Volltext

Verfügbarkeit prüfen

Opiate receptor antagonists for delusions of parasitosis

Biological psychiatry (1969), 1991-09, Vol.30 (5), p.530-531

1991

Link zum Volltext

Verfügbarkeit prüfen

Decreased levels of soluble intercellular adhesion Molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients

Biological psychiatry (1969), 2000-01, Vol.47 (1), p.29-33

2000

Link zum Volltext

Verfügbarkeit prüfen

Melanoma-Associated Adhesion Molecule MUC18/MCAM (CD146) and Transcriptional Regulator Mader in Normal Human CNS

Neuroimmunomodulation, 1998-09, Vol.5 (5), p.270-276

1998

Link zum Volltext

Verfügbarkeit prüfen

P300 and symptom improvement in schizophrenia

Psychopharmacologia, 2001-10, Vol.158 (1), p.55-65

2001

Link zum Volltext

Verfügbarkeit prüfen

Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease

Brain research, 1999-03, Vol.823 (1), p.104-112

1999

Link zum Volltext

Verfügbarkeit prüfen

Blood–cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia

Neuroscience letters, 1998-09, Vol.253 (3), p.201-203

1998

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130

Neuroscience letters, 1999-01, Vol.259 (3), p.145-148

1999

Link zum Volltext

Verfügbarkeit prüfen

Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis

Progress in neuro-psychopharmacology & biological psychiatry, 1993-09, Vol.17 (5), p.713-730

1993

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease

Neuroscience letters, 1997-06, Vol.228 (3), p.143-146

1997

Link zum Volltext

Verfügbarkeit prüfen

Impairment of retinal increment thresholds in Huntington's disease

Annals of neurology, 1993-10, Vol.34 (4), p.574-578

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Books

ThemaHumans

ThemaMiddle Aged

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

12 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study

Tourette syndrome is associated with insecure attachment and higher aggression

Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients

Tryptophan metabolism and immunogenetics in major depression: A role for interferon-γ gene

Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders

Prenatal immunologic predictors of postpartum depressive symptoms: a prospective study for potential diagnostic markers

Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder

Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study

ICAM G241A Polymorphism and Soluble ICAM-1 Serum Levels: Evidence for an Active Immune Process in Schizophrenia

Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6

Association between intracellular infectious agents and Tourette’s syndrome

Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

Cost of illness in patients with Gilles de la Tourette’s syndrome

Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics

A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome

Opiate receptor antagonists for delusions of parasitosis

Decreased levels of soluble intercellular adhesion Molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients

Melanoma-Associated Adhesion Molecule MUC18/MCAM (CD146) and Transcriptional Regulator Mader in Normal Human CNS

P300 and symptom improvement in schizophrenia

Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease

Blood–cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia

Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130

Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease

Impairment of retinal increment thresholds in Huntington's disease

Aktive Filter

Suchergebnisse filtern